Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jul;41(7):1439–1443. doi: 10.1128/aac.41.7.1439

Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment.

J T Frieling 1, J A Mulder 1, T Hendriks 1, J H Curfs 1, C J van der Linden 1, R W Sauerwein 1
PMCID: PMC163936  PMID: 9210662

Abstract

The in vitro production of interleukin-1beta (IL-1beta), IL-6, and the IL-1 receptor antagonist (IL-1ra) in whole blood upon stimulation with different bacterial strains was measured to study the possible relationship between disease severity and the cytokine-inducing capacities of these strains. Escherichia coli, Neisseria meningitidis, Neisseria gonorrhoeae, Bacteroides fragilis, Capnocytophaga canimorsus, Staphylococcus aureus, Enterococcus faecalis, Streptococcus pneumoniae, and Streptococcus pyogenes induced the cytokines IL-1beta, IL-6, and IL-1ra. Gram-negative bacteria induced significantly higher levels of proinflammatory cytokine production than gram-positive bacteria. These differences were less pronounced for the anti-inflammatory cytokine IL-1ra. In addition, blood was stimulated with E. coli killed by different antibiotics to study the effect of the antibiotics on the cytokine-inducing capacity of the bacterial culture. E. coli treated with cefuroxime and gentamicin induced higher levels of IL-1beta and IL-6 production but levels of IL-1ra production similar to that of heat-killed E. coli. In contrast, ciprofloxacin- and imipenem-cilastatin-mediated killing showed a decreased or similar level of induction of cytokine production as compared to that by heat-killed E. coli; polymyxin B decreased the level of production of the cytokines.

Full Text

The Full Text of this article is available as a PDF (170.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Artenstein A. W., Cross A. S. Inhibition of endotoxin reactivity by aminoglycosides. J Antimicrob Chemother. 1989 Nov;24(5):826–828. doi: 10.1093/jac/24.5.826-a. [DOI] [PubMed] [Google Scholar]
  2. Bingen E., Goury V., Bennani H., Lambert-Zechovsky N., Aujard Y., Darbord J. C. Bactericidal activity of beta-lactams and amikacin against Haemophilus influenzae: effect on endotoxin release. J Antimicrob Chemother. 1992 Aug;30(2):165–172. doi: 10.1093/jac/30.2.165. [DOI] [PubMed] [Google Scholar]
  3. Cohen J., McConnell J. S. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur J Clin Microbiol. 1986 Feb;5(1):13–17. doi: 10.1007/BF02013454. [DOI] [PubMed] [Google Scholar]
  4. Crosby H. A., Bion J. F., Penn C. W., Elliott T. S. Antibiotic-induced release of endotoxin from bacteria in vitro. J Med Microbiol. 1994 Jan;40(1):23–30. doi: 10.1099/00222615-40-1-23. [DOI] [PubMed] [Google Scholar]
  5. Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992 Apr;215(4):356–362. doi: 10.1097/00000658-199204000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Desch C. E., Kovach N. L., Present W., Broyles C., Harlan J. M. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res. 1989 Summer;8(2):141–146. [PubMed] [Google Scholar]
  7. Dofferhoff A. S., Esselink M. T., de Vries-Hospers H. G., van Zanten A., Bom V. J., Weits J., Vellenga E. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother. 1993 Mar;31(3):373–384. doi: 10.1093/jac/31.3.373. [DOI] [PubMed] [Google Scholar]
  8. Dokter W. H., Dijkstra A. J., Koopmans S. B., Stulp B. K., Keck W., Halie M. R., Vellenga E. G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-1 beta and interleukin-6 expression in human monocytes. A study of the molecular mechanisms involved in inflammatory cytokine expression. J Biol Chem. 1994 Feb 11;269(6):4201–4206. [PubMed] [Google Scholar]
  9. Eng R. H., Smith S. M., Fan-Havard P., Ogbara T. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):185–189. doi: 10.1016/0732-8893(93)90109-k. [DOI] [PubMed] [Google Scholar]
  10. Evans M. E., Pollack M. Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J Infect Dis. 1993 Jun;167(6):1336–1343. doi: 10.1093/infdis/167.6.1336. [DOI] [PubMed] [Google Scholar]
  11. Fekade D., Knox K., Hussein K., Melka A., Lalloo D. G., Coxon R. E., Warrell D. A. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med. 1996 Aug 1;335(5):311–315. doi: 10.1056/NEJM199608013350503. [DOI] [PubMed] [Google Scholar]
  12. Fischer L. J., Weyant R. S., White E. H., Quinn F. D. Intracellular multiplication and toxic destruction of cultured macrophages by Capnocytophaga canimorsus. Infect Immun. 1995 Sep;63(9):3484–3490. doi: 10.1128/iai.63.9.3484-3490.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Focà A., Matera G., Iannello D., Berlinghieri M. C., Liberto M. C. Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide. Antimicrob Agents Chemother. 1991 Oct;35(10):2161–2164. doi: 10.1128/aac.35.10.2161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Friedland I. R., Jafari H., Ehrett S., Rinderknecht S., Paris M., Coulthard M., Saxen H., Olsen K., McCracken G. H., Jr Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J Infect Dis. 1993 Sep;168(3):657–662. doi: 10.1093/infdis/168.3.657. [DOI] [PubMed] [Google Scholar]
  15. Frieling J. T., Sauerwein R. W., Wijdenes J., Hendriks T., van der Linden C. J. Soluble interleukin 6 receptor in biological fluids from human origin. Cytokine. 1994 Jul;6(4):376–381. doi: 10.1016/1043-4666(94)90061-2. [DOI] [PubMed] [Google Scholar]
  16. Frieling J. T., van Deuren M., Wijdenes J., van der Meer J. W., Clement C., van der Linden C. J., Sauerwein R. W. Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis. 1995 Feb;171(2):469–472. doi: 10.1093/infdis/171.2.469. [DOI] [PubMed] [Google Scholar]
  17. Granowitz E. V., Santos A. A., Poutsiaka D. D., Cannon J. G., Wilmore D. W., Wolff S. M., Dinarello C. A. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet. 1991 Dec 7;338(8780):1423–1424. doi: 10.1016/0140-6736(91)92725-h. [DOI] [PubMed] [Google Scholar]
  18. Hopkin D. A. Too rapid destruction of gram-negative organisms. Lancet. 1977 Sep 17;2(8038):603–604. doi: 10.1016/s0140-6736(77)91445-3. [DOI] [PubMed] [Google Scholar]
  19. Lisi P. J., Chu C. W., Koch G. A., Endres S., Lonnemann G., Dinarello C. A. Development and use of a radioimmunoassay for human interleukin-1 beta. Lymphokine Res. 1987 Summer;6(3):229–244. [PubMed] [Google Scholar]
  20. Mattsson E., Verhage L., Rollof J., Fleer A., Verhoef J., van Dijk H. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6. FEMS Immunol Med Microbiol. 1993 Oct;7(3):281–287. doi: 10.1111/j.1574-695X.1993.tb00409.x. [DOI] [PubMed] [Google Scholar]
  21. McConnell J. S., Cohen J. Release of endotoxin from Escherichia coli by quinolones. J Antimicrob Chemother. 1986 Dec;18(6):765–766. doi: 10.1093/jac/18.6.765. [DOI] [PubMed] [Google Scholar]
  22. Mertsola J., Ramilo O., Mustafa M. M., Sáez-Llorens X., Hansen E. J., McCracken G. H., Jr Release of endotoxin after antibiotic treatment of Gram-negative bacterial meningitis. Pediatr Infect Dis J. 1989 Dec;8(12):904–906. doi: 10.1097/00006454-198912000-00036. [DOI] [PubMed] [Google Scholar]
  23. Mohler J., Fantin B., Mainardi J. L., Carbon C. Influence of antimicrobial therapy on kinetics of tumor necrosis factor levels in experimental endocarditis caused by Klebsiella pneumoniae. Antimicrob Agents Chemother. 1994 May;38(5):1017–1022. doi: 10.1128/aac.38.5.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nerad J. L., Griffiths J. K., Van der Meer J. W., Endres S., Poutsiaka D. D., Keusch G. T., Bennish M., Salam M. A., Dinarello C. A., Cannon J. G. Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. J Leukoc Biol. 1992 Dec;52(6):687–692. doi: 10.1002/jlb.52.6.687. [DOI] [PubMed] [Google Scholar]
  25. Neu H. C. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am J Med. 1985 Aug 9;79(2A):2–13. doi: 10.1016/0002-9343(85)90254-2. [DOI] [PubMed] [Google Scholar]
  26. Prins J. M., Kuijper E. J., Mevissen M. L., Speelman P., van Deventer S. J. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect Immun. 1995 Jun;63(6):2236–2242. doi: 10.1128/iai.63.6.2236-2242.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rangel-Frausto M. S., Pittet D., Costigan M., Hwang T., Davis C. S., Wenzel R. P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995 Jan 11;273(2):117–123. [PubMed] [Google Scholar]
  28. Roumen R. M., Frieling J. T., van Tits H. W., van der Vliet J. A., Goris R. J. Endotoxemia after major vascular operations. J Vasc Surg. 1993 Nov;18(5):853–857. [PubMed] [Google Scholar]
  29. Shenep J. L., Barton R. P., Mogan K. A. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis. 1985 Jun;151(6):1012–1018. doi: 10.1093/infdis/151.6.1012. [DOI] [PubMed] [Google Scholar]
  30. Shenep J. L., Flynn P. M., Barrett F. F., Stidham G. L., Westenkirchner D. F. Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis. 1988 Mar;157(3):565–568. doi: 10.1093/infdis/157.3.565. [DOI] [PubMed] [Google Scholar]
  31. Timmerman C. P., Mattsson E., Martinez-Martinez L., De Graaf L., Van Strijp J. A., Verbrugh H. A., Verhoef J., Fleer A. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immun. 1993 Oct;61(10):4167–4172. doi: 10.1128/iai.61.10.4167-4172.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Valtonen M., Lauhio A., Carlson P., Multanen J., Sivonen A., Vaara M., Lähdevirta J. Capnocytophaga canimorsus septicemia: fifth report of a cat-associated infection and five other cases. Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):520–523. doi: 10.1007/BF02113430. [DOI] [PubMed] [Google Scholar]
  33. Van Den Berg C., de Neeling A. J., Schot C. S., Hustinx W. N., Wemer J., de Wildt D. J. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis. 1992;24(5):619–627. doi: 10.3109/00365549209054648. [DOI] [PubMed] [Google Scholar]
  34. Yokochi T., Kusumi A., Kido N., Kato Y., Sugiyama T., Koide N., Jiang G. Z., Narita K., Takahashi K. Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide. Antimicrob Agents Chemother. 1996 Oct;40(10):2410–2412. doi: 10.1128/aac.40.10.2410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. van Deuren M., van der Ven-Jongekrijg J., Bartelink A. K., van Dalen R., Sauerwein R. W., van der Meer J. W. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis. 1995 Aug;172(2):433–439. doi: 10.1093/infdis/172.2.433. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES